• Monday, September 16, 2024
businessday logo

BusinessDay

A journey through fear and support in the face of cervical health

More Nigerian women at risk of cervical cancer over cost of HPV vaccine

Temi, a vibrant 30-year-old woman, shared her adventures with her loving husband, Adam, who stood by her side through thick and thin.

Temi hadn’t been feeling like herself lately. She noticed a persistent dull ache in her lower abdomen, accompanied by unusual spotting between her periods. Concerned, Temi’s mind raced to the worst possible scenario: cervical cancer. She had heard about the symptoms and couldn’t shake off the fear that gripped her heart.

Unable to contain her worries, Temi confided in Adam, together, they scheduled an appointment with Temi’s gynaecologist, determined to confront whatever the problem was.

At the doctor’s office, Temi nervously recounted her symptoms, her mind flooded with dread. The doctor listened attentively before performing a thorough examination. After what felt like an eternity, the doctor delivered unexpected news: Temi did not have cervical cancer. Instead, her symptoms were caused by a benign condition that could be easily treated.

In the days that followed, Temi took proactive steps to prioritize her health and well-being. She committed to attending regular check-ups with her gynaecologist, determined not to let fear dictate her life.

Cervical cancer is a type of cancer that develops in the cervix, the lower part of the uterus that connects to the vagina. It is often caused by human papillomavirus (HPV), a common sexually transmitted infection. Cervical cancer typically progresses slowly, starting with abnormal cell changes in the cervix that may develop into cancer over time if left untreated.

Cervical cancer is a preventable and treatable disease, yet it remains a significant public health concern, especially in developing countries where access to screening and healthcare may be limited. Inadequate screening and delayed diagnosis contribute to the high mortality rates associated with cervical cancer, highlighting the importance of raising awareness and promoting early detection efforts.

Regular cervical cancer screening, starting at age 21 for most individuals, is essential for detecting abnormal cell changes in the cervix early on. The Pap smear, which involves collecting cells from the cervix for examination under a microscope, can identify precancerous or cancerous changes that may require further evaluation and treatment. Additionally, the HPV test can detect the presence of high-risk HPV strains that are associated with cervical cancer.

Vaccination against HPV is another crucial preventive measure, particularly for adolescents and young adults. The HPV vaccine is highly effective in protecting against the most common HPV strains that can lead to cervical cancer and other HPV-related cancers. By vaccinating both boys and girls before they become sexually active, we can reduce the prevalence of HPV infections and ultimately lower the risk of cervical cancer in future generations.

Beyond screening and vaccination, education and awareness initiatives play a vital role in empowering individuals to take charge of their cervical health. By providing accurate information about risk factors, symptoms, and preventive measures, we can empower people to make informed decisions about their health and seek timely medical care when needed.

In conclusion, cervical cancer is a significant public health issue that requires a multifaceted approach to prevention and early detection. Through regular screening, vaccination, and education, we can reduce the burden of cervical cancer and save lives around the world. Together, we can strive for a future where cervical cancer is a preventable and treatable disease for all.

Cervical cancer often begins with precancerous changes in the cells of the cervix, which may not cause any noticeable symptoms at first. As the cancer progresses, however, symptoms may begin to manifest.

One of the most common signs is abnormal vaginal bleeding, which can occur between periods, after intercourse, or after menopause. Additionally, women may experience increased vaginal discharge that may be tinged with blood, as well as pelvic pain or discomfort during intercourse. In some cases, advanced cervical cancer may cause urinary symptoms such as pain or blood in the urine, or bowel symptoms such as constipation or blood in the stool. It’s important to note that these symptoms can also be caused by conditions other than cervical cancer, but any persistent or unusual symptoms should prompt a visit to a healthcare provider for further evaluation.

By prioritising regular screening and taking proactive measures to prevent cervical cancer, individuals can protect themselves and their loved ones from this potentially life-threatening disease.